<DOC>
	<DOC>NCT03095066</DOC>
	<brief_summary>This is a multicenter, randomized, placebo-controlled study to evaluate AVP-786 for the treatment of neurobehavioral disinhibition including aggression, agitation, and irritability in participants with traumatic brain injury (TBI).</brief_summary>
	<brief_title>Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Neurobehavioral Disinhibition Including Aggression, Agitation, and Irritability in Patients With Traumatic Brain Injury</brief_title>
	<detailed_description>Eligible participants for this study must have a diagnosis of neurobehavioral disinhibition including aggression, agitation, and irritability that persists after brain injury. This is a multicenter, randomized, placebo-controlled study, consisting of up to 12 weeks of treatment.</detailed_description>
	<mesh_term>Brain Injuries</mesh_term>
	<mesh_term>Psychomotor Agitation</mesh_term>
	<mesh_term>Aggression</mesh_term>
	<criteria>Participants with traumatic brain injury (TBI) Participants with neurobehavioral disinhibition symptoms that are present after trauma or after recovery of consciousness Score of â‰¥4 on the modified Clinical Global Impression of Severity (mCGIS) scale and the Agitation/Aggression or Irritability/Lability subscales of the Neuropsychiatric Inventory (NPI) scale at screening and baseline Participants with a reliable caregiver Participants with a diagnosis of any preexisting developmental, mood, or anxiety disorder Participants with a history or current clinical symptoms of schizophrenia, schizoaffective disorder, bipolar disorder, or progressive dementia, either before or after the TBI</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>aggression</keyword>
	<keyword>agitation</keyword>
	<keyword>irritability</keyword>
	<keyword>non-penetrating brain injury</keyword>
	<keyword>traumatic brain injury</keyword>
	<keyword>AVP-786</keyword>
</DOC>